Belsomra and Fluconazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 82 people who take Belsomra and Fluconazole. Common interactions include weight increased among females, and pneumonia among males.

The phase IV clinical study analyzes what interactions people who take Belsomra and Fluconazole have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2023

82 people who take Belsomra and Fluconazole together, and have interactions are studied.


What is Belsomra?

Belsomra has active ingredients of suvorexant. It is used in insomnia. Currently, eHealthMe is studying from 12,480 Belsomra users.

What is Fluconazole?

Fluconazole has active ingredients of fluconazole. It is used in vaginal yeast infection. Currently, eHealthMe is studying from 66,338 Fluconazole users.

Number of Belsomra and Fluconazole reports submitted per year:

Belsomra and Fluconazole drug interactions.

Common Belsomra and Fluconazole drug interactions by gender *:

female:

  1. Weight increased
  2. Arthralgia
  3. Cerebral disorder
  4. Drug dependence
  5. Drug withdrawal syndrome
  6. Fall
  7. Spinal pain
  8. Abdominal discomfort
  9. Abscess limb
  10. Acne

male:

  1. Pneumonia
  2. Anaemia
  3. Pyrexia
  4. Chronic kidney disease
  5. Haemolytic anaemia
  6. Iron overload
  7. Malaise
  8. Myelodysplastic syndrome
  9. Osteoarthritis
  10. Pruritus


Common Belsomra and Fluconazole drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Nephrogenic anaemia
  3. Renal failure
  4. Nephrotic syndrome

40-49:

  1. Chronic kidney disease
  2. Dyspepsia
  3. Renal failure
  4. Renal injury
  5. Tubulointerstitial nephritis
  6. Gastrooesophageal reflux disease
  7. Acne
  8. Anxiety
  9. Bipolar disorder
  10. Cataract

50-59:

  1. Epilepsy
  2. Haemorrhoids
  3. Toothache
  4. Upper respiratory tract inflammation
  5. Crohn's disease
  6. Cytomegalovirus enterocolitis
  7. Weight decreased
  8. Lymphoma
  9. Septic shock
  10. Chronic kidney disease

60+:

  1. Platelet count decreased
  2. Pneumonia
  3. Melaena
  4. Nausea
  5. Spinal compression fracture
  6. Urinary tract infection
  7. Hepatic cirrhosis
  8. Neutrophil count decreased
  9. Pyrexia
  10. Gastrointestinal haemorrhage

Common conditions people have *:

  1. High Blood Pressure: 22 people, 26.83%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 19 people, 23.17%
  3. Constipation: 16 people, 19.51%
  4. Pain: 15 people, 18.29%
  5. Depression: 13 people, 15.85%
  6. Infection: 12 people, 14.63%
  7. Sleep Disorder: 11 people, 13.41%
  8. Multiple Myeloma (cancer of the plasma cells): 10 people, 12.20%
  9. Stress And Anxiety: 9 people, 10.98%
  10. Itching: 9 people, 10.98%

* Approximation only. Some reports may have incomplete information.

Do you take Belsomra and Fluconazole?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Drug side effects by duration, gender and age:

Common Belsomra drug interactions:

Browse interactions between Belsomra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fluconazole drug interactions:

Browse interactions between Fluconazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on suvorexant and fluconazole (the active ingredients of Belsomra and Fluconazole, respectively), and Belsomra and Fluconazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Belsomra and Fluconazole.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: